IBM completes acquisition of HRL Laboratories

IBM completed its acquisition of HRL Laboratories to bolster its quantum technology capabilities.

• HRL’s silicon-spin qubit expertise is set to complement IBM’s superconducting quantum computing hardware roadmap.
• The deal adds capabilities in quantum sensing, cryogenics, control electronics, packaging, interconnects, and quantum materials.
• IBM reiterated its fault-tolerant roadmap, including IBM Quantum Starling targeted for 2029, followed by Blue Jay in the mid-2030s.
• Boeing and General Motors will continue partnering with IBM and HRL on quantum applications and advanced technology development.